Tuesday, February 27, 2007

Cervical Cancer Vaccine

Gardasil is a new vaccine produced by Merck to protect girls and young women from the Human Papillomavirus types 6, 11, 16 and 18. This is protection from Cervical Cancer, Cervical Dysplasia and genital warts.

It consists of three doses. The second dose is 2 months after the first dose and the third doses is 4 months after the second dose. The duration of immunity has not been established.

The cost will be about $150.00 for each dose so we would like to know how many people would like to have the medication so it could be ordered.

Predictably, there is a rush to mandate the vaccine by lawmakers who see a great drop in the incidence of the diseases. Parental rights advocates disagree. New information indicates that perhaps the vaccine should include antibodies against HPV type 58 as well.

Monday, February 26, 2007

Gum disease linked to pancreatic cancer

I have done three Dental and Systemic Disease symposium in the last 12 months. I will be doing more.

The link with cancer and the mouth is becoming more important as more data flows in. Additionally, 20% of all atherosclerotic heart disease comes from the mouth – all of this the recognition that inflammation seems to be the root of all evil regardless of where it begins.

Dr. Joe

Gum disease linked to pancreatic cancer
UPI Consumer Health Correspondent

WASHINGTON, Jan. 16 (UPI) -- A large, prospective study has again identified a link between periodontal disease and a higher risk of pancreatic cancer, the fourth-leading cause of cancer death in the United States, experts reported Tuesday.

Researchers found men with periodontal, or gum, disease had a 63 percent higher risk of getting pancreatic cancer as compared to those without the condition.

"It's been a real struggle to understand the risk factors for a disease which is highly fatal and poorly understood," said senior author Dr. Charles Fuchs, a gastrointestinal oncologist at the Dana-Farber Cancer Institute in Boston.
Fuchs and colleagues at the Harvard School of Public Health gathered data from a group of 51,529 male health professionals -- mostly white dentists -- who were aged 40 to 75 years. The participants completed a questionnaire about their health every two years from 1986 to 2002. Of the group, 216 patients developed pancreatic cancer and 67 got periodontal disease. The researchers used statistical analyses to evaluate the risk of pancreatic cancer.

This study, which will be published Wednesday in the Journal of the National Cancer Institute, goes beyond the scope of previous studies by offering more detailed data, as well as drawing from a huge sample size, Fuchs said.
Two recent, smaller studies found the same connection between periodontal disease and pancreatic cancer, but experts agree they were not as reliable because some of the participants were smokers. Smoking is one of a few known risk factors for pancreatic cancer.

The researchers made sure smoking did not influence their results; in fact, eliminating smokers from their analyses revealed an even stronger association.

People who have severe periodontal disease or gingivitis also often have elevated levels of C-reactive protein in their blood, which is a marker of chronic inflammation.

This association motivated the team to investigate whether inflammation plays a role in the link between periodontal disease and pancreatic cancer.

Inflammation can cause cell mutation and proliferation, which in turn can promote tumor development. Persistent inflammation also seems to inhibit the body to allow cells to die -- a process called programmed cell death -- and that may lead to cancer. Chronic pancreatitis has also been associated with an elevated risk for cancer of the pancreas.
The pancreas is a digestive organ responsible for producing hormones and digestive enzymes. Pancreatic cancer affects around 33,000 people each year, and almost that many die each year from the disease.
Scientists know little about the cancer, particularly because people who get it usually die within months of diagnosis. It's also hard to detect and overwhelmingly resistant to treatment.

Pancreatic cancer is sometimes familial; it can be caused by cigarette smoking; and it often develops in African-Americans, particularly in Louisiana. Evidence also suggests type 2 diabetes, obesity and resistance to insulin can raise a person's risk.

Recent research has found periodontal disease may raise the risk for coronary heart disease -- a condition also driven by chronic inflammation.

The study was limited by its reliance on the participants to report their own health diagnoses. Even so, since most of the participants were dentists, Fuchs said, he expects most of the data is accurate. Because the study only observed phenomena, it is too early to draw conclusions about whether periodontal disease causes pancreatic cancer.

And although the study only looked at men, Fuchs and colleagues plan to focus on women in their upcoming research.

The research points to oral health as one more aspect of a healthy lifestyle that Americans, especially seniors, should follow, said Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society.

As research has begun to show, "a healthy mouth may be a healthy body as well," Lichtenfeld said.

© Copyright 2007 United Press International, Inc. All Rights Reserved.
United Press International, UPI, the UPI logo, and other trademarks and service marks, are registered or unregistered trademarks of United Press International, Inc. in the United States and in other countries.

Tuesday, February 20, 2007

Byetta Nausea Help

One of the doctors reported in that raw carrots taken prior to a meal will get rid of the nausea.

Several people reported that the nausea was tolerated well by just eating less. They felt that was what the treatment was all about. As a result they lost major amounts of weight and decreased waist size. 58 lbs of weight loss and a decrease and 6 inches off the waist was the report of the most recent patient.

Friday, February 2, 2007

Nausea and Byetta

I will be sending out a regular email concerning the use of Byetta for type 1 and 2 diabetes. I have observed many people dropping out for various reasons that could have been circumvented with a suggestion or two.

Nausea is one of the first things that people find incompatible with living with Byetta. Although it is frequently gone after a month, it will persist in 4% of patients. This is what we suggest.
1. Ginger in all forms, not sugar free, a short while before the shot.
2. Coca-cola

If the nausea persists, we use phenergan 25 mg pills for use in anticipation of problems.

It that does not work we retreat on the dosage of Byetta. That might be going back to the 5 mcg twice a day or switch to whatever dose given usually to only at bedtime.

Most of these things work and then we would just go slowly for a month or longer before we even think of raising the dose. It just takes longer to get to goal. Don’t even think it’s not possible to get there.

If you have dropped out, we are waiting to help you reach your goal. It’s your time.

Thursday, February 1, 2007

Anodyne Therapy

We have used the Anodyne therapy for diabetic peripheral neuropathy since the year 2000. We have published two scientific papers on this treatment in two different journals which can be found in my curriculum vitae on our web site.

There are about 10 companies that are now making similar devices to treat neuropathy. Near infrared light for healing is “Hot” in the healing world today.

Wound care is easy effective and nontoxic today if treatment is started early. Non antibiotic, non debridement therapy is burgeoning. Anodyne is being used in “all” the nursing homes have them in treatment of early pressure sores and incidental extremity wounds.

We have added a number of additional features to make the Anodyne successful. Increased use of l-arginine in higher doses during treatment, “Stoss” dosing of vitamin D, and the new shorter but more intense therapy equipment works even better.

We had a 95% rate of reversal with past therapy which is better now. Those for whom it did not work know who you are. There will be more to come in additional therapy for neuropathy soon. Some things are better in the world.

It’s your time.